AR074274A1 - Uso de tensioactivos cationicos para la inactivacion de toxinas - Google Patents

Uso de tensioactivos cationicos para la inactivacion de toxinas

Info

Publication number
AR074274A1
AR074274A1 ARP090104264A ARP090104264A AR074274A1 AR 074274 A1 AR074274 A1 AR 074274A1 AR P090104264 A ARP090104264 A AR P090104264A AR P090104264 A ARP090104264 A AR P090104264A AR 074274 A1 AR074274 A1 AR 074274A1
Authority
AR
Argentina
Prior art keywords
lae
use according
inactivation
ethyl
acid
Prior art date
Application number
ARP090104264A
Other languages
English (en)
Inventor
Abdul Gaffar
Bonvila Xavier Rocabayera
Original Assignee
Vedeqsa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vedeqsa Inc filed Critical Vedeqsa Inc
Publication of AR074274A1 publication Critical patent/AR074274A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3481—Organic compounds containing oxygen
    • A23L3/3508—Organic compounds containing oxygen containing carboxyl groups
    • A23L3/3517—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3526—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3544—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente se refiere al uso de una composición para la inactivación de toxinas que contienen tensioactivos catiónicos tales como L-arginato de etil-Nalfa-lauroílo HCI (LAE). Se ha verificado que los tensioactivos catiónicos tales como el L-arginato de etil-Nalfa-lauroílo HCI (LAE) y sus sales son agentes eficaces contra endotoxinas, exotoxinas y aflatoxinas. Reivindicación 1: Uso de un tensioactivo catiónico derivado de la condensación de ácidos grasos y aminoácidos básicos esterificados de la fórmula (1), donde X- es un contra ión derivado de un ácido orgánico o inorgánico, preferiblemente Br-, Cl-, o HSO4-, o un anión sobre la base de un compuesto fenólico; R1 es una cadena alquílica recta de un ácido graso saturado o un ácido hidroxílico que tiene 8 a 14 átomos ligados al grupo aminoácido alfa a través de una ligadura amídica; R2 es una cadena alquílica recta o ramificada de 1 a 18 átomos de carbono o un grupo aromático; R3 es como en el grupo de fórmulas (2) en donde n es 0 a 4, para la inactivación de endotoxinas (lipopolisacáridos, LPS) desprendidos por bacterias Gram-negativas, exotoxinas o aflatoxinas. Reivindicación 3: Uso según la reivindicación 1 en un procedimiento para el tratamiento del cuerpo humano o animal por administración oral, tópica o parenteral. Reivindicación 8: Uso según la reivindicación 7, caracterizado porque la administración parenteral puede consistir en una forma líquida estéril. Reivindicación 12: Uso según cualquiera de las reivindicaciones 1 a 11, caracterizado porque el compuesto es el éster etílico de clorhidrato de arginina (LAE).
ARP090104264A 2008-11-21 2009-11-04 Uso de tensioactivos cationicos para la inactivacion de toxinas AR074274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11670508P 2008-11-21 2008-11-21

Publications (1)

Publication Number Publication Date
AR074274A1 true AR074274A1 (es) 2011-01-05

Family

ID=41718757

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104264A AR074274A1 (es) 2008-11-21 2009-11-04 Uso de tensioactivos cationicos para la inactivacion de toxinas

Country Status (5)

Country Link
US (1) US20110230558A1 (es)
EP (1) EP2346501B1 (es)
AR (1) AR074274A1 (es)
ES (1) ES2600253T3 (es)
WO (1) WO2010057966A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010038952A1 (de) * 2010-08-05 2012-02-09 Henkel Ag & Co. Kgaa Konservierungsmittel-Zusammensetzungen und Kosmetika enthaltend diese
MX2018004052A (es) * 2015-10-02 2019-01-14 Ethicon Inc Metodos y sistemas para tratar fluidos y dispositivos medicos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758851B2 (en) * 2001-08-09 2010-07-20 Laboratorios Miret, S.A. Preservative systems and their use in cosmetic preparations
EP1437946B1 (en) * 2001-10-25 2012-06-13 Laboratorios Miret, S.A. Use of a cationic preservative in food products
EP2082724B1 (en) * 2001-11-15 2013-08-21 Laboratorios Miret, S.A. Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care
US20070140990A1 (en) * 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
US20080200890A1 (en) * 2006-12-11 2008-08-21 3M Innovative Properties Company Antimicrobial disposable absorbent articles

Also Published As

Publication number Publication date
EP2346501B1 (en) 2016-09-14
WO2010057966A1 (en) 2010-05-27
ES2600253T3 (es) 2017-02-08
EP2346501A1 (en) 2011-07-27
US20110230558A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
BR112013029240A2 (pt) derivados deuterados do ivacaftor
AR072462A1 (es) Uso de surfactantes cationicos como agentes esporicidas
DOP2016000250A (es) Una forma amorfa y una cristalina de hemitartrato genz 112638 como inhibidor de glucosilceramida sintasa
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
ECSP16025201A (es) Profármacos de amidas de piridona útiles como moduladores de canales de sodio
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
BR112017009601B8 (pt) Derivados de aminoácidos e composição que os compreende
BR112012013854A2 (pt) derivados de oxazina.
EA201692506A2 (ru) Ингибиторы репликации вирусов гриппа
AR063923A1 (es) Sales del acido zoledronico, procesos de preparacion y composiciones
AR084285A1 (es) Composiciones inmunogenicas
AR091089A1 (es) Metodos de tratamiento que utilizan un compuesto de biguanida en una formulacion de liberacion demorada
BR112014002670A2 (pt) uso de monoésteres de isossorbida como compostos antimicrobianamente ativos
AR076263A1 (es) Composiciones y metodos para tratar cancer. uso.
PE20141539A1 (es) Una nueva composicion terapeutica que contiene apomorfina como principio activo
BRPI0906444A8 (pt) compostos de 4-piridinona e seu uso para câncer
EA200800777A1 (ru) Применение сложных эфиров молочной кислоты для улучшения действия пестицидов
AR086824A1 (es) Composicion oftalmica que comprende un mediador lipido antiinflamatorio esterificado y metodo de tratamiento
BR112014002594A2 (pt) uso de diésteres de isossorbida como espessantes
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
CO6220906A2 (es) Surfactantes de alquilamidopropil dialquilamina como adyuvantes
PA8855001A1 (es) Monocarbamas
CO2017003321A2 (es) Inhibidores de gingipaina de lisina
BR112014002570A2 (pt) uso de monoésteres de isossorbida como espessantes
CL2011001363A1 (es) Proceso para la preparacion de un compuesto derivado de etorfina; compuesto derivado de etorfina; composicion farmaceutica que lo comprende; uso del compuesto como analgesico en el tratamiento del dolor.

Legal Events

Date Code Title Description
FB Suspension of granting procedure